Clinical Trial Results - Progress in Cancer Care
These summaries highlight recently released results from cancer clinical trials. The findings are significant enough that they are likely to influence your medical care.
The summaries are listed in reverse chronological order. You may also use the navigation tools on the left to search the summaries by keyword or type of cancer.
(Posted: 06/25/2007, Updated: 06/22/2010) - Women with breast cancer who take the drug trastuzumab (Herceptin®) are at risk of heart problems during treatment. Now a study has shown that the incidence of such problems does not increase in the short term, though the long-term effects remain unknown, according to findings presented at the 2007 ASCO meeting in Chicago.
Some Older Women Can Forgo Radiation after Breast Cancer Surgery
(Posted: 06/22/2010) - Women 70 years of age or older with early-stage breast cancer did not benefit from the addition of radiation therapy to breast-conserving surgery and tamoxifen, according to results of a phase III randomized study presented in advance of the 2010 American Society of Clinical Oncology annual meeting.
Sigmoidoscopy Markedly Reduces Colorectal Cancer Incidence and Mortality
(Posted: 05/11/2010) - A single sigmoidoscopy procedure reduced colorectal cancer incidence and mortality in a large randomized trial published online April 27, 2010, in The Lancet.
Cisplatin Plus Gemcitabine Improves Survival of Patients with Advanced Biliary Tract Cancer
(Posted: 05/11/2010) - Compared with gemcitabine (Gemzar®) alone, the chemotherapy combination of cisplatin (Platinol®) and gemcitabine improved overall survival of patients with locally advanced or metastatic biliary tract cancers, according to a study published April 10, 2010, in the New England Journal of Medicine.
Bortezomib Improves Survival of Newly Diagnosed Patients with Multiple Myeloma
(Posted: 09/11/2008, Updated: 05/04/2010) - The targeted drug bortezomib, when added to standard therapy (melphalan and prednisone), improves survival of patients with newly diagnosed multiple myeloma, according to the May 1, 2010, issue of the Journal of Clinical Oncology.